Return to content in this issue

Unveiling the Immunological Mechanism Underlying a Cutaneous Adverse Reaction to Enfortumab Vedotin: A Case Report Based on the Lymphocyte Transformation Test

Gutiérrez-Canales P^1,2, Fernández-Lozano C^2,3,4, Alba-Pérez V^1,2, Ruiz-Granados A⁵, Díaz-Montalvo L^2,3, Martínez-Botas J^2,3,4, Solano-Solares E<sup>1,2

1</sup>Allergology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain
²IRYCIS, Hospital Universitario Ramón y Cajal, Madrid, Spain
³Biochemistry-Research Department, Hospital Universitario Ramón y Cajal, Madrid, Spain
⁴Universidad de Alcalá, Madrid, Spain
⁵Medical Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain

J Investig Allergol Clin Immunol 2025; Vol. 35(1)
doi: 10.18176/jiaci.1023